FDA NDC Directory · JSON-LD · Markdown

zilganersen

NDC 68225-282 · DRUG FOR FURTHER PROCESSING · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerPatheon Italia S.p.A.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE
Active ingredientsZILGANERSEN SODIUM (56 mg/2.8mL)
Marketing started20260904
Package count1

External sources

Source: openFDA. Public-domain (CC0).